|
Dr. Chandra P. Leo
Chandra Leo is a Partner at HBM Partners AG and has fifteen years of experience in private equity, clinical practice and biomedical research. He is a former principal at Wellington Partners Venture Capital, focusing on life science investments. Previously he worked as a physician at University Hospital Leipzig (Germany) and as a postdoctoral scientist at Stanford University (USA).
Dr. Leo completed his medical studies in Berlin and London, and received his doctoral degree from Freie Universität Berlin (Charité). In addition he received an MBA degree with distinction from INSEAD. Chandra Leo is a former Board Member of ESBATech (acquired by Alcon), Board Observer at Anthera Pharmaceuticals (IPO NASDAQ) and Panomics (acquired by Affymetrix). He is currently Board Member of CardiacAssist and Board Observer at ChemoCentryx and Odyssey Thera.
|